Subscribe to RSS
DOI: 10.1055/s-2004-817603
© Georg Thieme Verlag Stuttgart · New York
Passivrauchen - aktueller Stand des Wissens
Environmental tobacco smoke exposure - current reviewPublication History
eingereicht: 7.5.2003
akzeptiert: 19.8.2003
Publication Date:
15 January 2004 (online)

Zusammenfassung
Passivrauch ist vermutlich die quantitativ bedeutsamste inhalative Noxe der Innenraumluft. In bevölkerungsbezogenen Untersuchungen geben 30-60 % aller Befragten an, regelmäßig gegenüber Passivrauch exponiert zu sein. Passivrauch ist durch die Senatskommission zur Bewertung gesundheitsgefährdender Arbeitstoffe der Deutschen Forschungsgemeinschaft als erwiesenermaßen humankanzerogener Arbeitsstoff eingestuft worden. Im Jahre 2002 wurde die Arbeitsstättenverordnung um einen Paragraphen „Nichtraucherschutz” ergänzt.
In international publizierten Metaanalysen einer Vielzahl epidemiologischer Studien zeigten sich für Bronchialkarzinome Relative Risiken (RR) von 1,1 bis 1,3. Das RR für koronare Herzkrankheiten lag bei 1,25 bis 1,35. Auch das RR für Atemwegssymptome, Asthma und chronische Bronchitis war konsistent erhöht. Dabei kann in den am höchsten exponierten Subgruppen das Relative Risiko auf den Faktor 2 erhöht sein.
Da bei ähnlich großen Relativen Risiken Herzerkrankungen wesentlich häufiger auftreten als Bronchialkarzinome, werden die Absolutzahlen der durch Passivrauchen verursachten Erkrankungen des Herz- und Gefäßsystems um den Faktor 5 - 10 höher eingeschätzt als die für das Bronchialkarzinom.
Summary
Among all indoor pollutants, environmental tobacco smoke (ETS) might be the most important. In population-based studies 30 to 60 % of the participants reported regular exposure to ETS. ETS has been classified as carcinogenic by several national and international agencies. In 2002, a paragraph on restriction of smoking at the workplace has been added to the German Workplaces Ordinance.
International meta-analyses have been published on the potential health effects of ETS exposure. In these studies, the pooled relative risk (RR) for lung cancer has been estimated between 1.1 and 1.3. The pooled risk estimate for coronary heart disease (CHD) was slightly higher (1.25 - 1.35). The RR in the group with the highest exposure might be as high as 2. An increased risk has also be shown consistently for respiratory symptoms, asthma, and COPD. Because of the high incidence of CHD the public health impact of ETS exposure on CHD might be higher than the impact due to additional lung cancer cases.
Literatur
- 1
Asgary S, Naderi G H, Sarrafzadegan N, Gharypur M.
In vitro effect of nicotine and cotinine on the susceptibility of LDL oxidation
and hemoglobin glycosylation.
Mol Cell Biochem.
2003;
246
117-120
MissingFormLabel
- 2
Boffetta P.
Involuntary smoking and lung cancer.
Scand J Work Environ Health.
2002;
28
30-40
(Suppl 2)
MissingFormLabel
- 3
Burney P.
The European Community Respiratory Health Survey II.
Eur Respir J.
2002;
20
1071-1079
MissingFormLabel
- 4
California-EPA (Environmental Protection Agency) .
Health Effects of Exposure to Environmental Tobacco Smoke.
Smoking and Tobacco Control Monograph.
1999;
10
2-47
MissingFormLabel
- 5
Danuser B, Weber A, Hartmann A L, Krueger H.
Effects of a bronchoprovocation challenge test with cigarette sidestream smoke
on sensitive and healthy adults.
Chest.
1993;
103
353-358
MissingFormLabel
- 6
Glantz S A, Parmley W W.
Passive smoking and heart disease. Mechanisms and risk.
JAMA.
1995;
273
1047-1053
MissingFormLabel
- 7 Greim H. Passivrauchen. Weinheim, VCH-Verlagsgesellschaft In: Greim H (Hrsg.) Gesundheitsschädliche Arbeitsstoffe - Toxikologisch-arbeitsmedizinische
Begründungen von MAK-Werten 1998 27. Auflage: 1-36
MissingFormLabel
- 8 Greim H. MAK- und BAT-Werte Liste 2002. Weinheim, Deutsche Forschungsgemeinschaft 2002 38. Auflage
MissingFormLabel
- 9
He J, Vupputuri S, Allen K, Prerost M R, Hughes J, Whelton P K.
Passive smoking and the risk of coronary heart disease - a meta-analysis of
epidemiologic studies.
N Engl J Med.
1999;
340
920-926
MissingFormLabel
- 10
Husgafvel-Pursiainen K.
Biomarkers in the assessment of exposure and the biological effects of environmental
tobacco smoke.
Scand J Work Environ Health.
2002;
28
21-29
(Suppl 2)
MissingFormLabel
- 11 International Agency for Research on Cancer (IARC) .Tobacco Smoke and Involuntary Smoking. IARC Monographs 2002 Volume 83
MissingFormLabel
- 12
Iso H, Shimamoto T, Sato S, Koike K, Iida M, Komachi Y.
Passive smoking and plasma fibrinogen concentrations.
Am J Epidemiol.
1996;
144
1151-1154
MissingFormLabel
- 13
Jaakkola J J, Jaakkola M S.
Effects of environmental tobacco smoke on the respiratory health of children.
Scand J Work Environ Health.
2002;
28
71-83
(Suppl 2)
MissingFormLabel
- 14
Jaakkola M S, Jaakkola J J.
Effects of environmental tobacco smoke on the respiratory health of adults.
Scand J Work Environ Health.
2002;
28
52-70
(Suppl 2)
MissingFormLabel
- 15
Jaakkola M S, Jaakkola J J, Becklake M R, Ernst P.
Effect of passive smoking on the development of respiratory symptoms in young
adults: an 8-year longitudinal study.
J Clin Epidemiol.
1996;
49
581-586
MissingFormLabel
- 16
Janson C, Chinn S, Jarvis D, Zock J P, Toren K, Burney P.
Effect of passive smoking on respiratory symptoms, bronchial responsiveness,
lung function, and total serum IgE in the European Community Respiratory Health
Survey: a cross-sectional study.
Lancet.
2001;
358
2103-2109
MissingFormLabel
- 17
Jarvis M J, Goddard E, Higgins V, Feyerabend C, Bryant A, Cook D G.
Children’s exposure to passive smoking in England since the 1980 s: cotinine
evidence from population surveys.
BMJ.
2000;
321
343-345
MissingFormLabel
- 18
Jarvis M J, Russell M A.
Measurement and estimation of smoke dosage to non-smokers from environmental
tobacco smoke.
Eur J Respir Dis Suppl.
1984;
133
68-75
MissingFormLabel
- 19
Jarvis M J, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y.
Comparison of tests used to distinguish smokers from nonsmokers.
Am J Public Health.
1987;
77
1435-1438
MissingFormLabel
- 20
Jockel K H, Pohlabeln H, Ahrens W, Krauss M.
Environmental tobacco smoke and lung cancer.
Epidemiology.
1998;
9
672-675
MissingFormLabel
- 21
Jousilahti P, Helakorpi S.
Prevalence of exposure to environmental tobacco smoke at work and at home -
5-year trends in Finland.
Scand J Work Environ Health.
2002;
28
16-20
(Suppl 2)
MissingFormLabel
- 22
Jousilahti P, Patja K, Salomaa V.
Environmental tobacco smoke and the risk of cardiovascular disease.
Scand J Work Environ Health.
2002;
28
41-51
(Suppl 2)
MissingFormLabel
- 23
Kreuzer M, Heinrich J, Kreienbrock L, Rosario A S, Gerken M, Wichmann H E.
Risk factors for lung cancer among nonsmoking women.
Int J Cancer.
2002;
100
706-713
MissingFormLabel
- 24
Leaderer B P, Samet J M.
Passive smoking and adults: new evidence for adverse effects.
Am J Respir Crit Care Med.
1994;
150
1216-1218
MissingFormLabel
- 25
Lee C H, Ko Y C, Goggins W. et al .
Lifetime environmental exposure to tobacco smoke and primary lung cancer of
non-smoking Taiwanese women.
Int J Epidemiol.
2000;
29
224-231
MissingFormLabel
- 26
Leuenberger P, Schwartz J, Ackermann-Liebrich U. et al .
Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA
Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team.
Am J Respir Crit Care Med.
1994;
150
1222-1228
MissingFormLabel
- 27
Maziak W, Rzeh ak P, Keil U, Weiland S K.
Smoking among adolescents in Münster, Germany: increase in prevalence (1995
- 2000) and relation to tobacco advertising.
Prev Med.
2003;
36
172-176
MissingFormLabel
- 28
Nafstad P, Magnus P, Jaakkola J J.
Early respiratory infections and childhood asthma.
Pediatrics.
2000;
106
E38
MissingFormLabel
- 29
Nowak D, Jorres R, Martinez-Muller L. et al .
Effect of 3 hours of passive smoke exposure in the evening on inflammatory markers
in bronchoalveolar and nasal lavage fluid in subjects with mild asthma.
Int Arch Occup Environ Health.
1997;
70
85-93
MissingFormLabel
- 30
Nowak D, Jorres R, Schmidt A, Magnussen H.
Effect of 3 hours’ passive smoke exposure in the evening on airway tone and
responsiveness until next morning.
Int Arch Occup Environ Health.
1997;
69
125-133
MissingFormLabel
- 31
Nowak D, Schön S.
Medikamentöse Verfahren zur Raucherentwöhnung.
Suchtmed Forsch Prax.
2002;
4
189-199
MissingFormLabel
- 32
Nyberg F, Pershagen G.
Passive smoking and lung cancer. Accumulated evidence on lung cancer and environmental
tobacco smoke.
BMJ.
1998;
317
347-348
MissingFormLabel
- 33
Pirkle J L, Flegal K M, Bernert J T, Brody D J, Etzel R A, Maurer K R.
Exposure of the US population to environmental tobacco smoke: the Third National
Health and Nutrition Examination Survey, 1988 to 1991.
JAMA.
1996;
275
1233-1240
MissingFormLabel
- 34
Radon K, Busching K, Heinrich J. et al .
Passive smoking exposure: a risk factor for chronic bronchitis and asthma in
adults?.
Chest.
2002;
122
1086-1090
MissingFormLabel
- 35
Sapigni T, Biavati P, Simoni M. et al .
The Po River Delta Respiratory Epidemiological Survey: an analysis of factors
related to level of total serum IgE.
Eur Respir J.
1998;
11
278-283
MissingFormLabel
- 36
Schwartz J, Zeger S.
Passive smoking, air pollution, and acute respiratory symptoms in a diary study
of student nurses.
Am Rev Respir Dis.
1990;
141
62-67
MissingFormLabel
- 37
Strachan D P, Cook D G.
Health effects of passive smoking. 6. Parental smoking and childhood asthma:
longitudinal and case-control studies.
Thorax.
1998;
53
204-212
MissingFormLabel
- 38
Tarlo S M, Broder I.
Irritant-induced occupational asthma.
Chest.
1989;
96
297-300
MissingFormLabel
- 39
Wells A J.
Heart disease from passive smoking in the workplace.
J Am Coll Cardiol.
1998;
31
1-9
MissingFormLabel
- 40
Wells A J, English P B, Posner S F, Wagenknecht L E, Perez-Stable E J.
Misclassification rates for current smokers misclassified as nonsmokers.
Am J Public Health.
1998;
88
1503-1509
MissingFormLabel
- 41
Wichmann H E, Jockel K H, Becher H.
Gesundheitliche Risiken durch Passivrauchen - Bewertung der epidemiologischen
Daten.
Umweltmed Forsch Prax.
1999;
4
28-42
MissingFormLabel
Priv.-Doz. Dr. Katja Radon
Arbeitsgruppe Arbeits- und Umweltepidemiologie & Net Teaching, Institut für Arbeits-
und Umweltmedizin
Ziemssenstraße 1
80336 München
Phone: 089/51602400
Fax: 089/51603957
Email: kradon@arbeits.med.uni-muenchen.de